The engineered CSC model described in this study represents a valuable experimental system for the study of basic CSC biology of KRAS-mutated lung adenocarcinoma, including the molecular mechanisms governing self-renewal and differentiation; and also should greatly contribute to the discovery and evaluation of novel therapeutic approaches and targets in CSCs of this intractable lung cancer. Here, KRAS is linked to lung cancer.